PMID: 11908674Mar 23, 2002Paper

Matrix metalloproteinases and cancer

Anticancer Research
G Cox, K J O'Byrne

Abstract

The extracellular matrix (ECM) is a framework of proteins and proteoglycans, secreted by and surrounding stromal fibroblasts. The ECM gives structural integrity to tissues. Remodelling of the ECM is essential for both tumour invasion and angiogenesis. There is abundant evidence to suggest that ECM degrading enzymes, including matrix metalloproteinases (MMPs), are involved in these processes. MMPs are novel targets for therapeutic intervention with the potential to inhibit tumour growth and invasion either on their own or in conjunction with cytotoxic treatments. This review outlines our current understanding of the regulation of MMP expression, the association of MMPs with tumour growth, invasion and angiogenesis and the clinical evolution of MMP inhibitors.

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Pia Vihinen, V M Kähäri
Cellular and Molecular Life Sciences : CMLS
N JohanssonV M Kähäri
Critical Reviews in Oncology/hematology
R Giavazzi, G Taraboletti
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
S Curran, G I Murray
© 2022 Meta ULC. All rights reserved